Tumour heterogeneity and the impact on patient care
5 Oct 2016
Tumour heterogeneity and the impact on patient care
Screening, surgical cure and new developments: How to avoid false positives in lung cancer screening
Screening, surgical cure and new developments: How to organise a national screening programme
Omics, early detection and novel therapies: Q & A
Immunotherapy in NSCLC
Immunotherapy in SCLC
Omics, early detection and novel therapies: Metabolomics
Small cell lung cancer: Q & A
Omics, early detection and novel therapies: Epigenetic studies
Small cell lung cancer: New therapies
Small cell lung cancer: Current standards of care
We should use PDL1 and other biomarkers for selecting patients for immune checkpoint therapies